JP2017533200A5 - - Google Patents

Download PDF

Info

Publication number
JP2017533200A5
JP2017533200A5 JP2017521550A JP2017521550A JP2017533200A5 JP 2017533200 A5 JP2017533200 A5 JP 2017533200A5 JP 2017521550 A JP2017521550 A JP 2017521550A JP 2017521550 A JP2017521550 A JP 2017521550A JP 2017533200 A5 JP2017533200 A5 JP 2017533200A5
Authority
JP
Japan
Prior art keywords
alkyl
ring
independently
alkoxy
aryb
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017521550A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017533200A (ja
Filing date
Publication date
Priority claimed from PCT/CN2014/089204 external-priority patent/WO2016061772A1/en
Application filed filed Critical
Publication of JP2017533200A publication Critical patent/JP2017533200A/ja
Publication of JP2017533200A5 publication Critical patent/JP2017533200A5/ja
Pending legal-status Critical Current

Links

JP2017521550A 2014-10-22 2015-10-21 ナルゲニシン化合物及び抗菌剤としてのそれの使用 Pending JP2017533200A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2014/089204 2014-10-22
PCT/CN2014/089204 WO2016061772A1 (en) 2014-10-22 2014-10-22 Nargenicin compounds and uses thereof as antibacterial agents
PCT/US2015/056627 WO2016064982A1 (en) 2014-10-22 2015-10-21 Nargenicin compounds and uses thereof as antibacterial agents

Publications (2)

Publication Number Publication Date
JP2017533200A JP2017533200A (ja) 2017-11-09
JP2017533200A5 true JP2017533200A5 (https=) 2019-10-17

Family

ID=55760063

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017521550A Pending JP2017533200A (ja) 2014-10-22 2015-10-21 ナルゲニシン化合物及び抗菌剤としてのそれの使用

Country Status (11)

Country Link
US (2) US9944654B2 (https=)
EP (1) EP3209667B1 (https=)
JP (1) JP2017533200A (https=)
KR (1) KR20170070197A (https=)
CN (1) CN107108646A (https=)
AU (1) AU2015335992A1 (https=)
BR (1) BR112017008101A2 (https=)
CA (1) CA2964377A1 (https=)
MX (1) MX2017005271A (https=)
RU (1) RU2017117253A (https=)
WO (2) WO2016061772A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016061772A1 (en) 2014-10-22 2016-04-28 Merck Sharp & Dohme Corp. Nargenicin compounds and uses thereof as antibacterial agents
KR102440647B1 (ko) 2020-07-28 2022-09-06 선문대학교 산학협력단 나르제니신 a1 유도체를 포함하는 항혈관신생용 조성물

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148883A (en) 1977-08-18 1979-04-10 Pfizer Inc. Antibiotics produced by new species of nocardia
US4360683A (en) * 1980-08-06 1982-11-23 The Upjohn Company Antibiotic nodusmicin derivatives
US4351769A (en) * 1980-08-25 1982-09-28 The Upjohn Company Antibiotic composition of matter
US4448970A (en) * 1981-02-19 1984-05-15 The Upjohn Company Nargenicin derivatives
US4436747A (en) 1982-10-21 1984-03-13 Pfizer Inc. Nargenicin C1
US4605624A (en) * 1982-10-21 1986-08-12 Pfizer Inc. Nocardia species capable of producing nargenicin C1
ES2258234T3 (es) 2002-08-12 2006-08-16 PHARMACIA & UPJOHN COMPANY LLC N-aril-2-oxazolidinonas y sus derivados.
GB0227701D0 (en) 2002-11-28 2003-01-08 Astrazeneca Ab Chemical compounds
MXPA05005522A (es) 2002-11-28 2005-07-25 Astrazeneca Ab Oxazolidinonas como agentes antibacterianos.
WO2005012270A2 (en) 2003-07-29 2005-02-10 Rib-X Pharmaceuticals, Inc. Biaryl heterocyclic amines, amides, and sulfur-containing compounds and methods of making and using the same
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
JP2008500318A (ja) 2004-05-25 2008-01-10 アストラゼネカ アクチボラグ 抗菌剤としての3−{4−(ピリジン−3−イル)フェニル}−5−(1h−1,2,3−トリアゾール−1−イルメチル)−1,3−オキサゾリジン−2−オン
WO2007133803A2 (en) 2006-05-15 2007-11-22 Rib-X Pharmaceuticals, Inc. Treatment of mycobacterial infections
WO2008069619A1 (en) 2006-12-08 2008-06-12 Legochem Bioscience Ltd. Novel oxazolidinone derivatives, process for preparing thereof and pharmaceutical composition containing the same
KR101040468B1 (ko) 2008-02-29 2011-06-09 조선대학교산학협력단 새로운 노카르디아 속 균주 및 그의 발효 배양물의 용도
KR101022564B1 (ko) 2008-12-19 2011-03-16 조선대학교산학협력단 나르제니신을 포함하는 염증성 신경퇴행성 질환의 치료용 제약 조성물
WO2011139832A2 (en) 2010-04-28 2011-11-10 Rib-X Pharmaceuticals, Inc. Method for treating mycobacterial infections
KR101561964B1 (ko) 2013-11-15 2015-10-20 한국과학기술연구원 옥사졸리디논 화합물 및 이를 포함하는 c형 간염 예방 또는 치료용 약학 조성물
WO2016061772A1 (en) 2014-10-22 2016-04-28 Merck Sharp & Dohme Corp. Nargenicin compounds and uses thereof as antibacterial agents

Similar Documents

Publication Publication Date Title
JP2016506962A5 (https=)
JP2019500387A5 (https=)
JP2013545785A5 (https=)
JP2014503525A5 (https=)
JP2014505735A5 (https=)
JP2016516043A5 (https=)
JP2017528467A5 (https=)
JP2018537535A5 (https=)
JP2013542261A5 (https=)
JP2015537020A5 (https=)
JP2017537949A5 (https=)
JP2016510038A5 (https=)
JP2017523169A5 (https=)
JP2016527217A5 (https=)
JP2017504635A5 (https=)
RU2016134751A (ru) Соединения
JP2013529196A5 (https=)
JP2016503793A5 (https=)
JP2013540713A5 (https=)
JP2013534248A5 (https=)
JP2017141277A5 (https=)
JP2006518328A5 (https=)
JP2016513696A5 (https=)
JP2016523955A5 (https=)
JP2021534095A5 (https=)